NPY and type 2 diabetes mellitus: Given that islet NPY/Y1 receptor levels are negatively correlated with the insulin stimulation index in human T2D, we next investigated whether pharmacological inhibition of NPY/Y1 receptor signaling by a selective Y1 receptor antagonist BIBO3304, under diabetogenic conditions, would restore β-cell function.